Legend:
CC = Colorado Convention Center H = Hyatt Regency Denver at Colorado Convention Center
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
644 * !
|
Thu, 8/1/2019,
10:30 AM -
12:20 PM
|
CC-607
|
|
Statistical Methods for the Co-Development of Drug and Companion Diagnostic in Oncology — Topic Contributed Papers
|
|
Section on Medical Devices and Diagnostics, Biopharmaceutical Section, Society for Medical Decision Making
|
|
Organizer(s): Rong Liu, Celgene
|
|
Chair(s): Frank Shen, Celgene Co.
|
|
10:35 AM
|
Evaluation of Biomarker Threshold Designs in Cancer Therapy
Kui Shen, Bayer U.S. LLC; Xiaowen Tian, University of Washington; Jonathan Siegel, Bayer HealthCare Pharmaceuticals Inc.
|
|
10:55 AM
|
A Case Study in Bridging for Companion Diagnostic Development: Pembrolizumab and PD-L1 Selected 2nd Line NSCLC Patients
Jared Lunceford, Merck & Co., Inc.; Ellie Corigliano, Merck & Co., Inc.; Siddhartha Mathur, Merck & Co., Inc.; Ziwen Wei, Merck & Co., Inc.; Yue Shentu, Merck & Co., Inc.
|
|
11:15 AM
|
Drug-Device Co-Development in the Era of Precision Medicine: Industry Perspectives on Statistical Challenges
Shunguang Wang, Novartis Institutes for BioMedical Research Inc.
|
|
11:35 AM
|
Logical Inference on Treatment Efficacy When Subgroups Exist
Ying Ding, University of Pittsburgh
|
|
11:55 AM
|
Innovative Designs for Drug-Device Co-Development in the Area of Precision Medicine
Rui Tang, Servier
|
|
12:15 PM
|
Floor Discussion
|
|
